A Randomized Open-Label Comparison of the Impact of Aripiprazole Versus Risperidone on Sexual Functioning (RAS Study)

被引：11
|
作者：
de Boer, Marrit K. [1 ]
Wiersma, Durk [1 ]
Bous, Johan
Sytema, Sjoerd [1 ]
van der Moolen, Andrea E. G. M. [2 ]
Wilffert, Bob [3 ]
Hamamura, Takashi [4 ]
Knegtering, Henderikus [5 ,6 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands
[2] Univ Groningen, Dept Med Sociol, Groningen, Netherlands
[3] Univ Groningen, Dept Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands
[4] Hamamura Clin, Kurashiki, Okayama, Japan
[5] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Neuroimaging Ctr Groningen, Groningen, Netherlands
[6] Lentis Fdn Mental Healthcare Groningen, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 31卷 / 04期
关键词：
INDUCED HYPERPROLACTINEMIA; ANTIPSYCHOTICS; OLANZAPINE; DISORDERS;
D O I：
10.1097/JCP.0b013e318222bb29
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：523 / 525
页数：3
相关论文
共 50 条
  • [1] A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning
    Knegtering, H.
    Boks, Marco
    Blijd, Carl
    Castelein, Stynke
    Van den Bosch, Robert J.
    Wiersma, Durk
    JOURNAL OF SEX & MARITAL THERAPY, 2006, 32 (04) : 315 - 326
  • [2] A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning
    Knegtering, R
    Castelein, S
    Bous, H
    van der Linde, J
    Bruggeman, R
    Kluiter, H
    van den Bosch, RJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 56 - 61
  • [3] Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol
    de Oliveira, Irismar Reis
    Elkis, Helio
    Gattaz, Wagner Farid
    Chaves, Ana Cristina
    de Sena, Eduardo Ponde
    de Matos e Souza, Fabio Gomes
    Campos, Joao Alberto
    Bueno, Joao Romildo
    Costa e Silva, Jorge Alberto
    Louza, Mario Rodrigues
    de Abreu, Paulo Belmonte
    CNS SPECTRUMS, 2009, 14 (02) : 93 - 102
  • [4] An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia
    Mozes, Tamar
    Ebert, Tanya
    Michal, Sabbagh-Etun
    Spivak, Baruch
    Weizman, Abraham
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (04) : 393 - 403
  • [5] Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study
    Fujioi, Junko
    Iwamoto, Kunihiro
    Banno, Masahiro
    Kikuchi, Tsutomu
    Aleksic, Branko
    Ozaki, Norio
    PHARMACOPSYCHIATRY, 2017, 50 (02) : 74 - 78
  • [6] The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine
    Kern, Robert S.
    Green, Michael F.
    Cornblatt, Barbara A.
    Owen, J. Randall
    McQuade, Robert D.
    Carson, William H.
    Ali, Mirza
    Marcus, Ron
    PSYCHOPHARMACOLOGY, 2006, 187 (03) : 312 - 320
  • [7] The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine
    Robert S. Kern
    Michael F. Green
    Barbara A. Cornblatt
    J. Randall Owen
    Robert D. McQuade
    William H. Carson
    Mirza Ali
    Ron Marcus
    Psychopharmacology, 2006, 187 : 312 - 320
  • [8] Switching to Aripiprazole in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
    Ryckmans, V.
    Kahn, J. P.
    Modell, S.
    Werner, C.
    McQuade, R. D.
    Kerselaers, W.
    Lissens, J.
    Sanchez, R.
    PHARMACOPSYCHIATRY, 2009, 42 (03) : 114 - 121
  • [9] Comparison of aripiprazole versus bupropion augmentation for treatment of older patients with MDD: a randomized prospective open-label multi-center study
    Kim, H. G.
    Lee, K. H.
    Park, Y. W.
    Lee, J. H.
    Koo, B. H.
    Lee, S. J.
    Sung, H. M.
    Cheon, E. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S437 - S438
  • [10] Improvement in global functioning in bipolar patients: Results from an open-label, risperidone study
    Rupnow, M
    Canuso, C
    Janicak, P
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S328 - S328
12345